Metabolic Treatments for Intractable Epilepsy

Seminars in Pediatric Neurology

Volumn 18, Issue 3, 2011, Pages 179-185

  Kelley, Sarah A ^a   Hartman, Adam L ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BROMINE DERIVATIVE; CLOBAZAM; LAMOTRIGINE; LONG CHAIN FATTY ACID; MEDIUM CHAIN TRIACYLGLYCEROL; PHENOBARBITAL; RUFINAMIDE; TOPIRAMATE;

DIET RESTRICTION; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE CONTROL; DRUG TREATMENT FAILURE; EPILEPTIC STATE; HUMAN; INTRACTABLE EPILEPSY; KETOGENIC DIET; LANDAU KLEFFNER SYNDROME; LENNOX GASTAUT SYNDROME; LOW GLYCEMIC INDEX TREATMENT; MEDIUM CHAIN TRIGLYCERIDE DIET; MODIFIED ATKINS DIET; MYOCLONIC ASTATIC EPILEPSY; PETIT MAL; REVIEW; SEVERE MYOCLONIC EPILEPSY IN INFANCY; TUBEROUS SCLEROSIS; WEST SYNDROME;

ANTICONVULSANTS; DIET THERAPY; DIET, CARBOHYDRATE-RESTRICTED; EPILEPSY; HUMANS; KETOGENIC DIET;

EID: 80655125254     PISSN: 10719091     EISSN: 15580776     Source Type: Journal    
DOI: 10.1016/j.spen.2011.06.004     Document Type: Review

References (68)

1. Epilepsy and Seizure Statistics The Epilepsy Foundation, Accessed March 1, 2011. http://www.epilepsyfoundation.org/about/statistics.cfm.
2. Berg A.T. Identification of pharmacoresistant epilepsy. Neurol Clin 2009, 27:1003-1013.
3. Wheless J.W. History of the ketogenic diet. Epilepsia 2008, 49(suppl 8):3-5.
4. Guelpa G., Marie A. La lutte contre l'ePilepsie par la de'sintoxication et par la re'e'ducation alimentaire. Rev Ther Medico-Chirugicale 1911, 78:8-13.
5. Geyelin H. Fasting as a method for treating epilepsy. Med Rec 1921, 99:1037-1039.
6. Lennox W.G. Progress in the study of epilepsy in America in 1937. Epilepsia 1939, B1:196-208.
7. Peterman M.G. Convulsions in childhood: Twenty year study of 2,500 cases. Am J Dis Child 1946, 72:399-410.
8. Kossoff E.H., Zupec-Kania B.A., Amark P.E., et al. Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009, 50:304-317.
9. Neal E.G., Chaffe H., Schwartz R.H., et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 2009, 50:1109-1117.
10. Kossoff E.H., Krauss G.L., McGrogan J.R., et al. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology 2003, 61:1789-1791.
11. Kossoff E.H., Dorward J.L., Turner Z., et al. Prospective study of the modified Atkins diet in combination with a ketogenic liquid supplement during the initial month. J Child Neurol 2010, 26:147-151.
12. Muzykewicz D.A., Lyczkowski D.A., Memon N., et al. Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy. Epilepsia 2009, 50:1118-1126.
13. Kwan P., Arzimanoglou A., Berg A.T., et al. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 2010, 51:1069-1077.
14. Patel A., Pyzik P.L., Turner Z., et al. Long-term outcomes of children treated with the ketogenic diet in the past. Epilepsia 2010, 51:1277-1282.
15. Kossoff E.H., Hedderick E.F., Turner Z., et al. A case-control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms. Epilepsia 2008, 49:1504-1509.
16. Neal E.G., Chaffe H., Schwartz R.H., et al. The ketogenic diet for the treatment of childhood epilepsy: A randomised controlled trial. Lancet Neurol 2008, 7:500-506.
17. Maydell B.V., Wyllie E., Akhtar N., et al. Efficacy of the ketogenic diet in focal versus generalized seizures. Pediatr Neurol 2001, 25:208-212.
18. Stainman R.S., Turner Z., Rubenstein J.E., et al. Decreased relative efficacy of the ketogenic diet for children with surgically approachable epilepsy. Seizure 2007, 16:615-619.
19. Caraballo R.H., Cersósimo R.O., Sakr D., et al. Ketogenic diet in patients with Dravet syndrome. Epilepsia 2005, 46:1539-1544.
20. Groomes L.B., Pyzik P.L., Turner Z., et al. Do patients with absence epilepsy respond to ketogenic diets?. J Child Neurol 2010, 26:150-155.
21. Wang D., Pascual J.M., Yang H., et al. Glut-1 deficiency syndrome: Clinical, genetic, and therapeutic aspects. Ann Neurol 2005, 57:111-118.
22. Wexler I.D., Hemalatha S.G., McConnell J., et al. Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology 1997, 49:1655-1661.
23. Kossoff E.H., Pyzik P.L., Rubenstein J.E., et al. Combined ketogenic diet and vagus nerve stimulation: Rational polytherapy?. Epilepsia 2007, 48:77-81.
24. Morrison P.F., Pyzik P.L., Hamdy R., et al. The influence of concurrent anticonvulsants on the efficacy of the ketogenic diet. Epilepsia 2009, 50:1999-2001.
25. Nabbout R., Mazzuca M., Hubert P., et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010, 51:2033-2037.
26. Wheless J.W. Treatment of refractory convulsive status epilepticus in children: Other therapies. Semin Pediatr Neurol 2010, 17:190-194.
27. Vanitallie T.B., Nonas C., Di Rocco A., et al. Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study. Neurology 2005, 64:728-730.
28. Henderson S.T., Vogel J.L., Barr L.J., et al. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: A randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond) 2009, 6:31.
29. Klein P., Janousek J., Barber A., et al. Ketogenic diet treatment in adults with refractory epilepsy. Epilepsy Behav 2010, 19:575-579.
30. Bergqvist A.G., Schall J.I., Gallagher P.R., et al. Fasting versus gradual initiation of the ketogenic diet: A prospective, randomized clinical trial of efficacy. Epilepsia 2005, 46:1810-1819.
31. Pfeifer H.H., Lyczkowski D.A., Thiele E.A. Low glycemic index treatment: Implementation and new insights into efficacy. Epilepsia 2008, 49(suppl 8):42-45.
32. Kossoff E.H., Laux L.C., Blackford R., et al. When do seizures usually improve with the ketogenic diet?. Epilepsia 2008, 49:329-333.
33. Marsh E.B., Freeman J.M., Kossoff E.H., et al. The outcome of children with intractable seizures: A 3- to 6-year follow-up of 67 children who remained on the ketogenic diet less than one year. Epilepsia 2006, 47:425-430.
34. Kossoff E.H., Turner Z., Bergey G.K. Home-guided use of the ketogenic diet in a patient for more than 20 years. Pediatr Neurol 2007, 36:424-425.
35. Martinez C.C., Pyzik P.L., Kossoff E.H. Discontinuing the ketogenic diet in seizure-free children: Recurrence and risk factors. Epilepsia 2007, 48:187-190.
36. Camfield P., Camfield C. The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy. Neurology 2005, 64:973-975.
37. Sillanpää M., Schmidt D. Prognosis of seizure recurrence after stopping antiepileptic drugs in seizure-free patients: A long-term population-based study of childhood-onset epilepsy. Epilepsy Behav 2006, 8:713-719.
38. Ranganathan L.N., Ramaratnam S. Rapid versus slow withdrawal of antiepileptic drugs. Cochrane Database Syst Rev 2006, 2. CD005003.
39. Vining E.P. Long-term health consequences of epilepsy diet treatments. Epilepsia 2008, 49(suppl 8):27-29.
40. Keene D.L. A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr Neurol 2006, 35:1-5.
41. Kang H.C., Kim Y.J., Kim D.W., et al. Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia 2005, 46:272-279.
42. Nordli D.R., Kuroda M.M., Carroll J., et al. Experience with the ketogenic diet in infants. Pediatrics 2001, 108:129-133.
43. Bank I.M., Shemie S.D., Rosenblatt B., et al. Sudden cardiac death in association with the ketogenic diet. Pediatr Neurol 2008, 39:429-431.
44. Sillanpää M., Jalava M., Kaleva O., et al. Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998, 338:1715-1722.
45. Kossoff E.H., Dorward J.L. The modified Atkins diet. Epilepsia 2008, 49(suppl 8):37-41.
46. Freeman J.M., Vining E.P., Kossoff E.H., et al. A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia 2009, 50:322-325.
47. Kilaru S., Bergqvist A.G. Current treatment of myoclonic astatic epilepsy: Clinical experience at the Children's Hospital of Philadelphia. Epilepsia 2007, 48:1703-1707.
48. Kelley S.A., Kossoff E.H. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev Med Child Neurol 2010, 52:988-993.
49. Kossoff EH, Cross JH: Ketogenic diets: Where do we go from here? Epilepsy Res (in press).
50. Neal E.G., Cross J.H. Efficacy of dietary treatments for epilepsy. J Hum Nutr Diet 2010, 23:113-119.
51. Lefevre F., Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics 2000, 105:E46.
52. Henderson C.B., Filloux F.M., Alder S.C., et al. Efficacy of the ketogenic diet as a treatment option for epilepsy: Meta-analysis. J Child Neurol 2006, 21:193-198.
53. Coppola G., Verrotti A., Ammendola E., et al. Ketogenic diet for the treatment of catastrophic epileptic encephalopathies in childhood. Eur J Paediatr Neurol 2010, 14:229-234.
54. Kumada T., Miyajima T., Oda N., et al. Efficacy and tolerability of modified Atkins diet in Japanese children with medication-resistant epilepsy. Brain Dev 2011, [Epub ahead of print].
55. Tonekaboni S.H., Mostaghimi P., Mirmiran P., et al. Efficacy of the Atkins diet as therapy for intractable epilepsy in children. Arch Iran Med 2010, 13:492-497.
56. Miranda M.J., Mortensen M., Povlsen J.H., et al. Danish study of a modified Atkins diet for medically intractable epilepsy in children: Can we achieve the same results as with the classical ketogenic diet?. Seizure 2010, 20:151-155.
57. Pfeifer H.H., Thiele E.A. Low-glycemic-index treatment: A liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 2005, 65:1810-1812.
58. The epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care National Institute for Clinical Excellence (NICE), Accessed March 4, 2011. http://www.nice.org.uk/nicemedia/pdf/CG020NICEguideline.pdf.
59. Mastriani K.S., Williams V.C., Hulsey T.C., et al. Evidence-based versus reported epilepsy management practices. J Child Neurol 2008, 23:507-514.
60. Pulsifer M.B., Gordon J.M., Brandt J., et al. Effects of ketogenic diet on development and behavior: Preliminary report of a prospective study. Dev Med Child Neurol 2001, 43:301-306.
61. Smith M., Politzer N., Macgarvie D., et al. Efficacy and tolerability of the modified Atkins diet in adults with pharmacoresistant epilepsy: A prospective observational study. Epilepsia 2011, [Epub ahead of print].
62. Siddiqui F., Herial N.A., Ali I.I. Cumulative effect of vagus nerve stimulators on intractable seizures observed over a period of 3 years. Epilepsy Behav 2010, 18:299-302.
63. Morgan C.L., Kerr M.P. Estimated cost of inpatient admissions and outpatient appointments for a population with epilepsy: A record linkage study. Epilepsia 2004, 45:849-854.
64. Mandel A., Ballew M., Pina-Garza J.E., et al. Medical costs are reduced when children with intractable epilepsy are successfully treated with the ketogenic diet. J Am Diet Assoc 2002, 102:396-398.
65. Sachdeo R.C., Glauser T.A., Ritter F., et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL study group. Neurology 1999, 52:1882-1887.
66. Motte J., Trevathan E., Arvidsson J.F., et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut study group. N Engl J Med 1997, 337:1807-1812.
67. Conry J.A., Ng Y.T., Paolicchi J.M., et al. Clobazam in the treatment of Lennox-Gastaut syndrome. Epilepsia 2009, 50:1158-1166.
68. Glauser T., Kluger G., Sachdeo R., et al. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 2008, 70:1950-1958.